Los Angeles Times: COVID-19 clinical trial
Publication mentions UC's efforts to study a drug used in organ transplantation to treat the virus
In a race to find medicines that can tame the coronavirus and treat patients with COVID-19, researchers are scouring the formulary of available drugs and chemical compounds in hopes of finding something they could put to work immediately.
As a result, dozens of existing medicines have been waved through to clinical trials in record time.
Among those medicines is an immune-suppressing drug, called sirolimus, which is being studied in a novel clinical trial at UC. Sirolimus is used to reduce rejection episodes in organ transplant patients and to treat lymphangioleiomyomatosis, or LAM, a rare lung disease. UC researchers were pioneers in discovering this rare lung disease as well as finding an effective treatment for it.
Dr. Nishant Gupta is leading the sirolimus trial at UC, and he received a pilot grant to help execute it.
Read more about clinical trials being conducted at UC.
Featured photo/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Tags
Related Stories
Love it or raze it?
February 20, 2026
An architectural magazine covered the demolition of UC's Crosley Tower.
Social media linked to student loneliness
February 20, 2026
Inside Higher Education highlighted a new study by the University of Cincinnati that found that college students across the country who spent more time on social media reported feeling more loneliness.
Before the medals: The science behind training for freezing mountain air
February 19, 2026
From freezing temperatures to thin mountain air, University of Cincinnati exercise physiologist Christopher Kotarsky, PhD, explained how cold and altitude impact Olympic performance in a recent WLWT-TV/Ch. 5 news report.